Migraine Without Aura Clinical Trial
Official title:
Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine? A Randomized Controlled Clinical Trial
This study will highlight and validate chiropractic spinal manipulative therapy (CSMT) for migraine. If the method proves to be effective, it will provide a new non-pharmacological treatment option for migraine. This is especially important since some migraineurs do not tolerate acute and/or prophylactic medicine, due to side effects or contraindications due to comorbidity of other diseases while others do not have effect. Thus, alternative treatment options are warranted. The applied methodology of the study will aim towards the highest possible research standards. This international study is a collaboration between Akershus University Hospital, University of Oslo (UiO), Norway and Macquarie University, Australia. The multidisciplinary professional backgrounds are physiotherapy, chiropractic and medicine. By increasing the methodological quality of the investigators research to a very high level, the investigators see the method to work as a guide to increase the quality of chiropractic research in the future, as previous randomized clinical trials (RCTs) of migraine used methodology showing room for improvement.
Migraine is characterized by a unilateral pulsating moderate/severe headache which is
aggravated by routine physical activity, and is accompanied by photo- and/or phonophobia,
nausea and sometimes vomiting. Migraine exists in two forms, migraine without aura (MO) and
migraine with aura (MA). Aura is reversible neurological disturbances of the vision, sensory
and/or speech, which occur prior to the headache. The aura symptoms show intra-individual
variations. The origin of migraine pain is still debated, since the origin of painful
impulses in the trigeminal nerve is still uncertain. Some argues for central and other argues
for peripheral mechanisms. Extracranial pain sensitive structures include skin, muscles,
arteries, periosteum and joints. The skin is sensitive to all usual forms of pain stimuli,
while especially temporal and neck muscles may be sources for pain and tenderness in
migraine. Similarly is the frontal supraorbital, superficial temporal, posterior and
occipital arteries sensitive to pain. It has been hypothesize that CSMT might relieve
migraine due to stimulation of different mechanoreceptors in the neck such as the
zygapophyseal joints, intervertebral discs and neck muscles. Numerous studies of
manipulations have been conducted, but all had one or more methodological shortcomings, i.e.
failure to specify diagnostic criteria, inadequate or no randomization procedure, lack of
control, lack of patient blinding, lack of specified primary and secondary end points and
shortcomings of statistical evaluation of the results. A few RCTs suggest that CSMT using
diversified technique is an effective therapy for migraine. The diversified technique is used
by 91% of chiropractors, and include a collections of procedures, hence the name diversified.
It focuses on inter-segmental pretension (soft tissue tension) prior to the delivery of high
velocity low amplitude (HVLA) adjustment. The Gonstead method is used by 59% of chiropractors
and is also based on HVLA, but a major difference is the minimal usage of rotation in all
adjustments in contrast to the diversified technique. The Gonstead method is considered safe,
since severe adverse reactions have not been encountered. No studies have previously
investigated the efficacy of the Gonstead method for migraine, although research in other
CSMT modalities has been recommended.
Study hypothesis CSMT using the Gonstead method reduces days with migraine by at least 25% as
compared to placebo (sham manipulation, i.e. broad non-specific contact, non-directional, low
velocity and low amplitude) and no intervention (control group).
The RCT is single blinded, placebo-controlled trial of CSMT using the Gonstead method vs.
sham manipulation and control group. If the treatment shows to be effective, the participants
whom receive sham manipulation or control will be offered true intervention after the
follow-up period and free of charge. This study will follow the recommendations set by the
clinical trial guidelines from the IHS, while the methodological quality control will in
general follow previous suggested criteria and the CONSORT statements.
Patients will be recruited through Akershus University Hospital, Norway as well as through
media advertising in Akershus and Oslo County. The diagnoses are set by a chiropractor and a
neurologist with experience in headache. In accordance with good clinical practice, all
patients will receive written and oral information about the project and will be informed
about the harms and benefits as well as adverse reaction of the intervention. A total of 90
participants need to be recruited to the clinical trial.
The clinical trials consist of three stages: Run-in, intervention (treatment) and follow-up.
One month of baseline data collection where participants will fill-in a diagnostic headache
diary. Baseline demographics and clinical characteristics will be presented in tables with
mean and standard deviation (SD) for each group.
As age and genders may plays a role, participants will be subdivided into four subgroups by
age and gender prior to the concealed group allocation and restricted randomization by
drawing prepared sealed lots. Each lot includes three different interventions, i.e active
treatment, sham manipulation and control group. The first three participants will draw from
the same lot until all three interventions are used. The next lot with three interventions is
then followed by the next three participants; each participant will only receive one
intervention.
The RCT will be conducted by an experienced chiropractor. Active treatment consists of CSMT
using the Gonstead method. A specific contact, high velocity, low amplitude, short lever,
with no recoil post adjustment directed to spinal biomechanical dysfunction diagnosed by
standard chiropractic tests.
Follow-up at 3, 6 and 12 months post-treatment. During this period participants continue to
fill in a diagnostic headache diary. The control group will also be included in this phase of
the study.
The data will be analyzed with SPSS using standard statistical techniques.
The investigators based the calculation of sample size on migraine days from recent group
comparison studies of topiramate. The investigators calculated that a sample size of 16
patients was required in each group to detect a difference in mean reduction in monthly
migraine headache days of 2.5 with 80% power, with p=0.05 as level of significance, and
assuming a common SD of 2.5 for active treatment and broad-based treatment groups.
Insurance is through "The Norwegian System of Compensation to Patients" (NPE) which is an
independent national body, set up to process compensation claims from patients who have
suffered an injury as a result of treatment under the Norwegian health service.
The Regional Committee for Medical Research Ethics (REK) in Norway and Norwegian Social
Science Data Services approved the full PhD research protocol. The declaration of helsinski
is followed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02202486 -
Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI
|
N/A | |
Completed |
NCT01687660 -
Acupuncture for Migraine Prophylaxis
|
N/A | |
Completed |
NCT00363532 -
Functional MRI (fMRI) in CGRP Induced Migraine
|
N/A | |
Completed |
NCT00123201 -
Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
|
Phase 2 | |
Completed |
NCT04406649 -
A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
|
Phase 3 | |
Completed |
NCT03874832 -
A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT05565001 -
The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.
|
N/A | |
Completed |
NCT04533568 -
Ibuprofen in Migraine Patients
|
Phase 4 | |
Recruiting |
NCT06459635 -
Migraine Attack Pain Phase Prediction Study
|
||
Recruiting |
NCT05416476 -
Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
|
Phase 3 | |
Completed |
NCT04636359 -
Study the Effect of Acupuncture on Migraine Patient Without Aura Via Functional Magnetic Resonance Imaging.
|
N/A | |
Completed |
NCT00534560 -
Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
|
Phase 2 | |
Terminated |
NCT04936061 -
Transnasal Cooling for Migraine
|
N/A | |
Recruiting |
NCT05281770 -
Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
|
||
Completed |
NCT00380263 -
PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
|
N/A | |
Completed |
NCT00334178 -
Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
|
Phase 3 | |
Recruiting |
NCT06051604 -
Mi-Helper Transnasal Cooling for Acute Treatment of Migraine
|
N/A | |
Recruiting |
NCT06414044 -
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
|
||
Completed |
NCT03472378 -
Can DFN-15 Terminate Migraine With Allodynia?
|
Phase 2 | |
Recruiting |
NCT05211154 -
Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine
|
Phase 4 |